RIVANNA MEDICAL, INC.

RIVANNA MEDICAL, INC. specializes in the design and development of advanced medical diagnostic devices, with a focus on ultrasound-based, radiation-free technologies for rapid clinical triage in high-stress environments. Their technical expertise lies in integrating real-time imaging systems with portable, field-deployable hardware to enable bedside fracture detection, particularly in mass casualty scenarios such as blast trauma. The company demonstrates proficiency in biomedical engineering, sensor fusion, and point-of-care diagnostic algorithm development, with a clear specialization in non-ionizing imaging modalities that reduce clinical bottlenecks without exposing patients or providers to radiation. Their innovation centers on accelerating triage decision-making in emergency and battlefield settings, distinguishing them through clinically validated, rapid-response medical device platforms. RIVANNA MEDICAL has delivered solutions to the Department of Health and Human Services, primarily supporting public health and emergency medical response initiatives. Their engagement reflects a targeted partnership focused on advancing trauma care technologies within federal health systems, particularly where speed, safety, and portability are critical to patient outcomes. The company’s primary industry focus is research and development in the life sciences, specifically in the design of diagnostic medical devices that bridge engineering innovation with clinical need. They operate at the intersection of biomedical engineering and emergency medicine, positioning themselves as a niche developer of next-generation point-of-care imaging systems for trauma and disaster response. RIVANNA MEDICAL, INC. is a small business structured as a 2L entity, headquartered in Charlottesville, Virginia. While currently holding no formal government certifications, their technical work aligns with FDA-regulated medical device development standards and federal procurement requirements for clinical innovation. Their geographic presence and market positioning reflect a focused commitment to advancing U.S. government medical readiness through specialized, high-impact device development.